Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $472.99 million. The enterprise value is $254.11 million.
Important Dates
The next estimated earnings date is Monday, November 4, 2024, after market close.
Earnings Date | Nov 4, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MNMD has 73.33 million shares outstanding. The number of shares has increased by 39.00% in one year.
Shares Outstanding | 73.33M |
Shares Change (YoY) | +39.00% |
Shares Change (QoQ) | +57.34% |
Owned by Insiders (%) | 1.01% |
Owned by Institutions (%) | 39.50% |
Float | 59.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.30 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.12.
Current Ratio | 5.92 |
Quick Ratio | 5.81 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -121.13 |
Financial Efficiency
Return on equity (ROE) is -66.26% and return on invested capital (ROIC) is -34.03%.
Return on Equity (ROE) | -66.26% |
Return on Assets (ROA) | -27.57% |
Return on Capital (ROIC) | -34.03% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 57 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +161.13% in the last 52 weeks. The beta is 2.36, so MNMD's price volatility has been higher than the market average.
Beta (5Y) | 2.36 |
52-Week Price Change | +161.13% |
50-Day Moving Average | 5.99 |
200-Day Moving Average | 7.16 |
Relative Strength Index (RSI) | 57.07 |
Average Volume (20 Days) | 621,703 |
Short Selling Information
The latest short interest is 10.21 million, so 13.93% of the outstanding shares have been sold short.
Short Interest | 10.21M |
Short Previous Month | 10.36M |
Short % of Shares Out | 13.93% |
Short % of Float | 17.21% |
Short Ratio (days to cover) | 14.93 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -90.48M |
Pretax Income | -125.32M |
Net Income | -102.04M |
EBITDA | n/a |
EBIT | -90.48M |
Earnings Per Share (EPS) | -$2.05 |
Full Income Statement Balance Sheet
The company has $243.13 million in cash and $24.25 million in debt, giving a net cash position of $218.88 million or $2.98 per share.
Cash & Cash Equivalents | 243.13M |
Total Debt | 24.25M |
Net Cash | 218.88M |
Net Cash Per Share | $2.98 |
Equity (Book Value) | 202.05M |
Book Value Per Share | 2.80 |
Working Capital | 205.85M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -73.78M |
Capital Expenditures | n/a |
Free Cash Flow | -73.78M |
FCF Per Share | -$1.01 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.00% |
Shareholder Yield | -39.00% |
Earnings Yield | -21.57% |
FCF Yield | -15.60% |
Analyst Forecast
The average price target for MNMD is $28.75, which is 345.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $28.75 |
Price Target Difference | 345.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Aug 29, 2022 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |